Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials

We measured immunosuppression at myeloma diagnosis and assessed the impact on survival in 5826 UK myeloma trial patients. Polyclonal immunoglobulin levels were below normal in 85% of patients and above normal in only 0.4% of cases for IgA, 0.2% for IgM and no cases for IgG. Immunoparesis had a great...

Descripción completa

Detalles Bibliográficos
Autores principales: Heaney, Jennifer L. J., Campbell, John P., Iqbal, Gulnaz, Cairns, David, Richter, Alex, Child, J. Anthony, Gregory, Walter, Jackson, Graham, Kaiser, Martin, Owen, Roger, Davies, Faith, Morgan, Gareth, Dunn, Janet, Drayson, Mark T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087716/
https://www.ncbi.nlm.nih.gov/pubmed/29925902
http://dx.doi.org/10.1038/s41375-018-0163-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087716/
https://www.ncbi.nlm.nih.gov/pubmed/29925902
http://dx.doi.org/10.1038/s41375-018-0163-4

Ejemplares similares